Roche Alecensa gets USFDA nod for ALK-positive early-stage lung cancer Ruchika Sharma20 April 2024 12:05 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following...
Roche gets CE Mark for companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for Enhertu Ruchika Sharma12 April 2024 12:54 PM ISTTucson: Roche has announced the approval of the CE Mark for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx to identify...
Roche gets USFDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis Ruchika Sharma11 April 2024 5:47 PM ISTBasel: Roche has announced that its Elecsys pTau217 assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration...
Roche Diagnostics India launches point-of-care NT-proBNP test for screening diabetes patients at cardiovascular diseases risk Ruchika Sharma11 April 2024 1:15 PM ISTMumbai: Roche Diagnostics India has announced the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of...
Roche gets USFDA approval for molecular test to screen for malaria in blood donors Ruchika Sharma30 March 2024 2:30 PM ISTThe cobas Malaria test, a qualitative in vitro nucleic acid screening test, allows for direct detection of Plasmodium RNA and DNA in whole blood...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Crovalimab study Dr. Divya Colin16 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Roche cutting jobs in product development: Report Ruchika Sharma12 Feb 2024 2:06 PM ISTZurich: Roche is cutting 345 jobs, Swiss website Muula reported, as the drugs company responds to lower profit posted for 2023 and a more cautious...
Roche gets European Commission marketing nod for Tecentriq SC for multiple cancer types Ruchika Sharma20 Jan 2024 11:24 AM ISTBasel: Roche has announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)'s...
Roche enters into agreement to acquire LumiraDx Point of Care technology combining multiple diagnostic modalities on single platform Ruchika Sharma30 Dec 2023 11:27 AM ISTBasel: Roche has announced the entry into a definitive agreement to acquire select parts of the LumiraDx group related to LumiraDx's innovative...
Roche Xolair gets USFDA priority review for children, adults with food allergies Ruchika Sharma20 Dec 2023 12:41 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted, under Priority Review, the company's supplemental...
Roche joins race for obesity drugs with USD 2.7 billion Carmot deal Ruchika Sharma5 Dec 2023 1:30 PM ISTRoche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to...
CDSCO Panel approves Roche's PMS Study Report of Rituximab with Glucocorticoids in Wegener's Granulomatosis Dr. Divya Colin3 Dec 2023 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved a post-marketing...
